•
Dec 31, 2020
Harrow Q4 2020 Earnings Report
Harrow Health's momentum continued, with revenue increasing and operating income rising significantly.
Key Takeaways
Harrow Health reported a strong fourth quarter in 2020, with a 16% increase in total revenues and a significant rise in operating income. The company's financial performance reflected a continuation of the momentum seen in the previous quarter.
Total revenues increased by 16% to $14.6 million compared to the same period in 2019.
Operating income rose to $2.6 million, compared to $0.9 million in the prior year.
Gross margins remained consistent at 73% compared to 72% in the fourth quarter of 2019.
Adjusted EBITDA reached a new high of $4.0 million, compared to $2.1 million in the prior-year period.